ICES brings together the best and brightest scientific talent. Many of our scientists are internationally recognized in their fields and receive national and international awards and recognition for their important work.
2018: Awarded to Dr. Hilary Brown in partnership with the Institute of Human Development, Child and Youth Health for "Infants born to women with disabilities: health and healthcare."
2018: Dr. Simone Vigod appointed for a five year term. The chair is based at Women’s College Hospital (WCH), in collaboration with the Centre for Addiction and Mental Health (CAMH) at the University of Toronto.
2017: Dr. Jeremy Grimshaw was selected by Clarivate Analytics as one the most highly cited researchers of 2017. This annual list identifies researchers who have published a high number of papers that rank within the top 1% of most-cited works in their field during its year of publication.
2017: Dr. Peter Austin was selected by Clarivate Analytics as one the most highly cited researchers of 2017. This annual list identifies researchers who have published a high number of papers that rank within the top 1% of most-cited works in their field during its year of publication.
2017: Awarded to Dr. Moira Stewart by the North American Primary Care Research Group. Read more.
2017: Awarded to Dr. Jacques Raphael for the paper "Palbociclib in hormone receptor positive advanced breast cancer: a cost-utility analysis."
2017-2019: Awarded to Dr. Morgan Slater by the Canadian Institutes of Health Research for the project "Managing chronic pain in primary care – linking clinical and administrative data to identify opportunities for quality improvement."
2017: Dr. David Marsh inducted Fellow, American Society of Addiction Medicine.
2017: Presented to Dr. Husam Abdel-Qadir by the Canadian Cardiac Oncology Network for "A score to predict cardiovascular disease risk after early stage breast cancer."
2017: Awarded to Drs. Laura Rosella and David Henry for the paper “Risk of bias in systematic reviews of non-randomized studies of adverse cardiovascular effects of thiazolidinediones and cyclooxygenase-2 inhibitors: application of a new Cochrane risk of bias tool” by Cochrane at its annual summit. The prize is offered annually and explicitly acknowledges Cochrane's value of criticism, with a view to helping to improve its work, and thus achieve its aim of helping people make well-informed decisions about healthcare by providing the best possible evidence on the effects of healthcare interventions.